Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsBlue Cross Blue Shield RI prior auth MDR Drug List…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - Rhode IslandPolicy Y0146_2020MedMDR_C

    Medical-benefit prior authorization for specified drugs (MDR Drug Listing)

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Rhode Island Policy Y0146_2020MedMDR_C alerts

    Get alerted when Policy Y0146_2020MedMDR_C changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Notifies Medicare Advantage members and providers that, effective July 1, 2020, an expanded list of drugs administered under the medical benefit will require prior authorization handled by Prime Therapeutics for BCBSRI members; applies to office and hospital outpatient administrations.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyMedical-benefit prior authorization for specified drugs (MDR Drug Listing)
    Policy CodePolicy Y0146_2020MedMDR_C
    Change TypeAdded prior authorization requirement for expanded MDR drug list
    Effective DateJuly 1, 2020
    Next Review Date
    Key ActionProviders, members, or their representatives must contact Prime Therapeutics to request prior authorization by phone, fax, online, or written letter.
    SourceLink
    POLICY UPDATE CHANGES

    An expanded list of drugs that may be covered under the medical benefit for Medicare Advantage plans will require prior authorization effective July 1, 2020.

    ~180drugs listed
    7/1/2020

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    effective
    Prime Therapeuticsprocessor
    1-800-693-6651phone

    Coverage Criteria

    This notice clarifies that the listed medications are covered under the medical benefit and are generally administered in a provider setting (e.g., a doctor’s office or hospital outpatient clinic). These drugs are distinct from Medicare Part D pharmacy-dispensed medications that members pick up at a retail pharmacy.

    Provider Actions Required

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for the expanded list of drugs administered under the medical benefit for Medicare Advantage plans effective July 1, 2020. Prior authorizations will be handled by Prime Therapeutics, LLC.

    • Effective date: July 1, 2020
    • Applies to drugs listed in the MDR Drug Listing (effective 7/1/20)
    Documentation Required

    How to Submit Prior Authorization Requests

    Requests for prior authorization must be submitted to Prime Therapeutics, LLC. Requests may be made by the provider, the member, or the member's representative.

    • Phone: 1-800-693-6651 (TTY: 711)
    • Fax: 855-212-8110
    • Online: www.myprime.com
    • Mail: Prime Therapeutics, Attn: Part B Benefit Requests, 2900 Ames Crossing Rd., Eagan, MN 55121
    • Hours: 24 hours a day, 7 days a week
    Step Therapy

    Step Therapy

    No step therapy rules are specified in this document; the listing identifies drugs that will require prior authorization but does not impose step therapy requirements.

    Note

    Timing of Requests

    Requests for prior authorization submitted before July 1, 2020 cannot be received and therefore will not be processed.

    Site of Care / Applicability

    Note

    Site of care: office or hospital outpatient (medical benefit)

    The drugs listed are typically those administered in a doctor's office or hospital outpatient clinic and are covered under the medical benefit; prior authorization applies when administration is billed under the medical benefit.

    Definitions

    MDR Drug Listing — key facts
    List nameMDR Drug Listing (Effective 7/1/20)
    PurposeExpanded list of medical-benefit drugs that will require prior authorization for Medicare Advantage plans effective July 1, 2020.
    Number of listed drugs (approx.)~180 (items listed on the MDR Drug Listing)
    Prior authorization processorPrime Therapeutics, LLC (beginning July 1, 2020).
    How to request prior authorizationCall 1-800-693-6651 (TTY 711), fax 855-212-8110, visit www.myprime.com, or send written requests to Prime Therapeutics, Attn: Part B Benefit Requests, 2900 Ames Crossing Rd., Eagan, MN 55121.

    Background

    This letter informs providers and members that, effective July 1, 2020, BCBSRI will require prior authorization for an expanded list of drugs billed under the medical benefit for Medicare Advantage plans. Prior authorizations will be processed by Prime Therapeutics, LLC beginning on that date; requests submitted before July 1, 2020 will not be received or processed. Providers, members, or their representatives must contact Prime Therapeutics to request prior authorization by phone at 1-800-693-6651 (TTY: 711), fax at 855-212-8110, online at www.myprime.com, or by written letter to Prime Therapeutics, Attn: Part B Benefit Requests, 2900 Ames Crossing Rd., Eagan, MN 55121.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyMedical-benefit prior authorization for specified drugs (MDR Drug Listing)
    Policy CodePolicy Y0146_2020MedMDR_C
    Change TypeAdded prior authorization requirement for expanded MDR drug list
    Effective DateJuly 1, 2020
    Next Review Date
    Key ActionProviders, members, or their representatives must contact Prime Therapeutics to request prior authorization by phone, fax, online, or written letter.
    SourceLink
    On This Page
    Coverage CriteriaProvider Actions RequiredSite of Care / ApplicabilityDefinitionsBackground